WaveMan · Form 4
Adams Brian insider trades
> Search tickers & screens ⌘K
LIVE

Adams Brian insider trades

Adams Brian has filed 41 Form 4s with the SEC that we hold, for Relay Therapeutics, Inc. (RLAY) (Chief Legal Officer) and Kymera Therapeutics, Inc. (KYMR) (Chief Legal Officer). Across all of them we count 0 purchases worth $0 and 39 sales worth $2.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($744.3K). The largest single trade was a sale of 3,025 shares of Kymera Therapeutics, Inc. worth $353.4K, dated 2026-09-04. Of 3 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-09-13 and the latest 2026-09-04.

Relay Therapeutics, Inc. (RLAY)

Chief Legal Officer · 38 filings · 36 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-13S, sale reported on Form 46,500$227.6K2021-09-13
2021-09-27S, sale reported on Form 4293$10.8K2021-09-27
2021-11-15S, sale reported on Form 46,500$230.2K2021-11-16
2021-12-27S, sale reported on Form 4295$9.8K2021-12-27
2022-03-29S, sale reported on Form 4333$9.9K2022-03-31
2022-04-28S, sale reported on Form 4708$18.1K2022-05-02
2022-06-27S, sale reported on Form 4300$6.1K2022-06-28
2022-07-28S, sale reported on Form 4734$15.6K2022-07-29
2022-09-27S, sale reported on Form 4294$6.7K2022-09-29
2022-10-28S, sale reported on Form 4728$15.7K2022-11-01
2022-12-27S, sale reported on Form 4295$4.3K2022-12-28
2023-01-12S, sale reported on Form 49,994$199.9K2023-01-13
2023-01-30S, sale reported on Form 4864$18.6K2023-01-31
2023-03-27S, sale reported on Form 4347$5.3K2023-03-28
2023-04-28S, sale reported on Form 41,936$21.6K2023-06-01
2023-04-28S, sale reported on Form 4863$9.6K2023-05-01
2023-06-27S, sale reported on Form 4294$3.6K2023-06-28
2023-07-28S, sale reported on Form 41,628$19.2K2023-07-31
2023-09-27S, sale reported on Form 4294$2.5K2023-09-29
2023-10-30S, sale reported on Form 41,632$9.8K2023-11-01
2023-12-27S, sale reported on Form 4294$3.4K2023-12-29
2024-01-29S, sale reported on Form 41,929$18.6K2024-01-31
2024-03-27S, sale reported on Form 4348$2.7K2024-03-29
2024-04-29S, sale reported on Form 41,623$10.4K2024-04-29
2024-06-27S, sale reported on Form 4295$1.8K2024-07-01
2024-07-29S, sale reported on Form 41,638$14.5K2024-07-31
2024-09-27S, sale reported on Form 4295$2.2K2024-10-01
2024-10-28S, sale reported on Form 41,632$9.9K2024-10-30
2024-12-27S, sale reported on Form 4299$1.3K2024-12-31
2025-01-28S, sale reported on Form 433,688$156.0K2025-01-30
2025-01-30S, sale reported on Form 420,791$91.9K2025-01-30
2025-03-27S, sale reported on Form 4298$8462025-03-31
2025-04-28S, sale reported on Form 41,644$5.2K2025-04-30
2025-04-30S, sale reported on Form 412,943$38.8K2025-04-30
2025-07-28S, sale reported on Form 41,637$6.1K2025-07-30
2025-07-29S, sale reported on Form 418,276$67.3K2025-07-30

Kymera Therapeutics, Inc. (KYMR)

Chief Legal Officer · 3 filings · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2026-09-04S, sale reported on Form 41,209$139.7K2026-09-04
2026-09-04S, sale reported on Form 43,025$353.4K2026-09-04
2026-09-04S, sale reported on Form 42,137$251.2K2026-09-04
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1636994) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms